Lumenis Be Ltd - Strategic SWOT Analysis Review

Lumenis Be Ltd - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Lumenis Be Ltd (Lumenis), an investment portfolio company of Baring Private Equity Asia, is an energy-based medical device company for aesthetic, surgical and ophthalmic applications in the field of minimally invasive clinical solutions. It manufactures and distributes medical and aesthetic lasers and light-based systems. Its major products include holmium lasers, CO2 lasers, re-usable fibers, multi-wavelength lasers, laser photocoagulator and other aesthetic devices. Lumenis designs surgical lasers and delivery devices for office and hospital settings. The company offers its solutions to a variety of medical environments, including aesthetic, ophthalmic and surgical procedures. Lumenis has operational presence in the Americas, Europe, the Middle East and Asia-Pacific. The company markets its products through subsidiaries in the US, China, Japan, India, Germany, and Australia and through distributors the world over. Lumenis is headquartered in Yokneam, Israel.

Lumenis Be Ltd Key Recent Developments

Sep 02,2021: Boston Scientific acquires surgical business of Lumenis for $1.07bn
Jul 14,2021: Lumenis announced the launch of a comprehensive global educational platform called MOSES HoLEP University that will enable urologists to offer...
May 13,2021: MOSES wins Silver Award at the Medical Design Excellence Awards (MDEA)
Mar 24,2021: Lumenis announces Nicholson Center as new center of excellence, hosts successful transoral endoscopic laser microsurgery program
Mar 04,2021: Boston Scientific to acquire Lumenis’ surgical business for $1.07bn

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.